Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor

Cancer Research

Volumn 61, Issue 2, 2001, Pages 687-693

  Boushey, R P ^a   Yusta, B ^a   Drucker, D J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; FLUOROURACIL; GLUCAGON LIKE PEPTIDE 2; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; HORMONE RECEPTOR; IRINOTECAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; INTESTINE INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BACTERIAL INFECTIONS; CAMPTOTHECIN; CELL LINE; CELL SURVIVAL; FEMALE; FLUOROURACIL; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HUMANS; INTESTINES; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PEPTIDES; RATS; RECEPTORS, GLUCAGON; SURVIVAL RATE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035863327     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Recommended guidelines for the treatment of chemotherapy-induced diarrhea
2. Diffuse mucosal damage in the large intestine associated with irinotecan (CPT-11)
3. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia
4. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis
5. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
6. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury, and mortality
7. FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury
8. Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model
9. Interleukin-1 1 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation
10. Transforming growth factor-β3 protection of epithelial cells from cycle-selective chemotherapy in vitro
11. Induction of intestinal epithelial proliferation by glucagon-like peptide 2
12. Regulation of the biological activity of glucagon-like peptide 2 by dipeptidyl peptidase IV
13. The glucagon-like peptides
14. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice
15. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis
16. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002
17. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-I- piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors
18. The measurement of villus cell population size in the mouse small intestine in normal and abnormal states: A comparison of absolute measurements with morphometric estimators in sectioned immersion-fixed material
19. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation
20. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia
21. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine
22. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation
23. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor
24. Sequential operation of ceramide synthesis and ICE cascade in CPT-1 l-initiated apoptotic death signaling
25. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis
26. Colorectal cancer prevention and treatment
27. Animal models for studying the action of topoisomerase I targeted drugs
28. Irinotecan (CPT-1 l) and characteristic mucosal changes in the mouse ileum and cecum
29. GLP-2 augments the adaptive response to massive intestinal resection in rat
30. Glucagon-like peptide-2 enbances epithelial barrier function of both transcellular and paracellular pathways in the mouse
31. γ,-Ray-induced apoptosis in transgenic mice with proliferative abnormalities in their intestinal epithelium: Re-entry of villus enterocytes into the cell cycle does not affect their radioresistance hut enhances the radiosensitivity of the crypt by inducing p53
32. Apoptosis in intestinal epithelium: Lessons from transgenic and knockout mice
33. Interdependent regulation of intracellular acidification and SHP-I in apoptosis
34. l cell cycle arrest
35. Apoptosis mediated by activation of the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP)
36. Human [Gly2]-GLP-2 reduces the severity of colonic injury in a routine model of experimental colitis
37. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion